AssetMark’s Forte Biosciences FBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-34
Closed -$723 – 3811
2026
Q2
$723 Sell
34
-12
-26% -$285 ﹤0.01% 3217
2026
Q1
$1.19K Sell
46
-12
-21% -$346 ﹤0.01% 2999
2025
Q4
$1.58K Sell
58
-23
-28% -$403 ﹤0.01% 2826
2025
Q3
$1.22K Buy
+81
New +$933 ﹤0.01% 2744

Other funds holding FBRX

AssetMark's FBRX Position: Q3 2026 in Review

AssetMark sold out of Forte Biosciences (FBRX) in Q3 2026, closing a stake of 34 shares — an estimated $723 sold.

AssetMark first reported a position in FBRX in Q3 2025 and held it in 4 quarters. The position peaked at $1.58K in Q4 2025. 2 funds tracked by Wall St. Rank hold FBRX as of Q3 2026.

  • AssetMark reported no remaining Forte Biosciences position as of Q3 2026 after selling out during the quarter.
  • AssetMark sold 34 Forte Biosciences shares in Q3 2026, an estimated $723.
  • AssetMark first reported a position in Forte Biosciences in Q3 2025 and held it in 4 quarters.
  • AssetMark's Forte Biosciences position peaked at $1.58K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.